We are live on
!
Find out more
QT
Quantbot Technologies Portfolio holdings
AUM
$2.44B
1-Year Est. Return
17.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.68%
1 Year Est. Return
+17.13%
3 Year Est. Return
+22.15%
5 Year Est. Return
-1.03%
10 Year Est. Return
+28.04%
AUM
$2.44B
AUM Growth
-$562M
(-19%)
Cap. Flow
-$483M
Cap. Flow
% of AUM
-19.75%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
2,271
New
617
Increased
487
Reduced
545
Closed
621
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$16.5M |
| 2 |
Microsoft
MSFT
|
+$14.8M |
| 3 |
General Dynamics
GD
|
+$14.3M |
| 4 |
Norfolk Southern
NSC
|
+$13.3M |
| 5 |
TJX Companies
TJX
|
+$12.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$21.8M |
| 2 |
MRSH
Marsh
MRSH
|
+$19M |
| 3 |
PayPal
PYPL
|
+$18.6M |
| 4 |
Micron Technology
MU
|
+$17.4M |
| 5 |
Viking Holdings
VIK
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Industrials | 15.89% |
| 3 | Technology | 14.9% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
CytomX Therapeutics
CTMX
$725M
| $5.31K | ﹤0.01% |
+1,130
| New | +$5.74K |
|
|
ZBIO
1577
Zenas BioPharma
ZBIO
$1.99B
| $5K | ﹤0.01% |
+256
| New | +$5.75K |
|
1578
Kodiak Sciences
KOD
$2.62B
| $4.73K | ﹤0.01% |
+124
| New | +$3.2K |
|
1579
Spyre Therapeutics
SYRE
$8.61B
| $4.44K | ﹤0.01% |
+88
| New | +$3.32K |
|
1580
Schrodinger
SDGR
$1.12B
| $4.32K | ﹤0.01% |
+380
| New | +$5.25K |
|
1581
Carlyle Secured Lending
CGBD
$717M
| $4.25K | ﹤0.01% |
388
-37,968
| -99% | -$448K |
|
1582
Elbit Systems
ESLT
$37.1B
| $4.25K | ﹤0.01% |
5
-2,018
| -100% | -$1.55M |
|
1583
Amdocs
DOX
$5.44B
| $4.18K | ﹤0.01% |
64
-46,092
| -100% | -$3.37M |
|
1584
Compass Minerals
CMP
$1.26B
| $4.16K | ﹤0.01% |
178
-45,841
| -100% | -$1.08M |
|
1585
Maravai LifeSciences
MRVI
$1.05B
| $4.06K | ﹤0.01% |
1,436
-58,887
| -98% | -$200K |
|
1586
ICF International
ICFI
$1.39B
| $4.05K | ﹤0.01% |
+62
| New | +$5.04K |
|
1587
Emergent Biosolutions
EBS
$391M
| $3.83K | ﹤0.01% |
+461
| New | +$4.78K |
|
1588
Compass Therapeutics
CMPX
$367M
| $3.81K | ﹤0.01% |
+720
| New | +$4.16K |
|
1589
Pulse Biosciences
PLSE
$2.27B
| $3.48K | ﹤0.01% |
+161
| New | +$2.97K |
|
1590
Janux Therapeutics
JANX
$953M
| $3.2K | ﹤0.01% |
230
-15,118
| -99% | -$207K |
|
|
BLLN
1591
BillionToOne Inc
BLLN
$5.94B
| $3.16K | ﹤0.01% |
+40
| New | +$3.27K |
|
1592
Target Hospitality
TH
$1.66B
| $3.05K | ﹤0.01% |
+329
| New | +$2.61K |
|
1593
National Presto Industries
NPK
$879M
| $3.02K | ﹤0.01% |
+22
| New | +$2.82K |
|
1594
Indonesia Energy Corp
INDO
$47.7M
| $2.98K | ﹤0.01% |
+865
| New | +$3.65K |
|
1595
Spire Global
SPIR
$442M
| $2.97K | ﹤0.01% |
+236
| New | +$2.52K |
|
|
AIFF
1596
Firefly Neuroscience
AIFF
$17.6M
| $2.91K | ﹤0.01% |
+1,333
| New | +$1.66K |
|
1597
Immunome
IMNM
$2.59B
| $2.87K | ﹤0.01% |
+131
| New | +$2.92K |
|
|
CSGS
1598
DELISTED
CSG Systems International
CSGS
| $2.72K | ﹤0.01% |
+34
| New | +$2.71K |
|
1599
Ironwood Pharmaceuticals
IRWD
$639M
| $2.65K | ﹤0.01% |
+756
| New | +$3.1K |
|
1600
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
| $2.55K | ﹤0.01% |
+29
| New | +$2.64K |
|
Similar funds
RL
TMC
GWM
KFA
BW
M
BBA
PUI
Quantbot Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Quantbot Technologies held 2,271 positions worth $2.44B, down 19% from $3.01B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Quantbot Technologies withdrew a net $483M in Q1 2026, closing 621 positions and reducing 545 holdings. Its most notable exit was Marsh, an estimated $19M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
Against the trend, Quantbot Technologies opened a new position in Alphabet (Google) Class A worth $15.1M.
- Quantbot Technologies's largest Q1 2026 buy was Alphabet (Google) Class A: 52,403 shares worth $15.1M.
- Quantbot Technologies added most to Microsoft in Q1 2026, an estimated $14.8M increase.
- Quantbot Technologies's biggest Q1 2026 reduction was Teradyne, cutting an estimated $21.8M.
- Quantbot Technologies fully exited Marsh in Q1 2026, selling an estimated $19M.
- Quantbot Technologies's ten largest holdings make up 6.4% of its $2.44B portfolio in Q1 2026.
- Quantbot Technologies opened 617 new positions and closed 621 in Q1 2026.
- Quantbot Technologies's portfolio value fell 19% quarter-over-quarter to $2.44B.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.